Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Trump says “pharma getting away with murder,” stocks slide
January 12, 2017 Off

Trump says “pharma getting away with murder,” stocks slide

By Dino Mustafić

U.S. President-elect Donald Trump on Wednesday said pharmaceutical companies are “getting away with murder” in what they charge the government for medicines, and promised that would change, sending drugs stocks sharply lower.

Walloon (Belgium) government funds ASIT Biotech’s food allergies treatment research
January 12, 2017 Off

Walloon (Belgium) government funds ASIT Biotech’s food allergies treatment research

By Dino Mustafić

The Walloon (Belgium) government has decided to fund its ASIT Biotech to help develop new drug candidates to treat the main food allergies caused by peanuts, cow’s milk and egg whites.

OptiBiotix with two abstracts at Berlin’s conference ProBiota
January 12, 2017 Off

OptiBiotix with two abstracts at Berlin’s conference ProBiota

By Dino Mustafić

OptiBiotix Health will have its two abstracts presented at ProBiota 2017 in Berlin, which is taking place from February 1-3, 2017. ProBiota is the leading annual event for the global prebiotic, probiotic and the microbiota focused food and pharma industries.

Mereo’s COO and CFO Richard Bugay joins Diurnal as CFO, UK drugmakers shuffle managers
January 12, 2017 Off

Mereo’s COO and CFO Richard Bugay joins Diurnal as CFO, UK drugmakers shuffle managers

By Dino Mustafić

Two UK-based biopharma companies, Mereo BioPharma and Diurnal have reshuffled their managerial lineups by swapping managers and welcoming new people.

MaxCyte’s in Demonstrates CRISPR-Cas9 X-linked CGD gene repair study
January 12, 2017 Off

MaxCyte’s in Demonstrates CRISPR-Cas9 X-linked CGD gene repair study

By Dino Mustafić

MaxCyte has been engaged in a study with National Institutes of Health’s (NIH) allergy and infection section to show certain CYBB gene behaviour in patients with X-linked chronic granulomatous disease (X-CGD).

Ablynx starts Phase IIb RESPIRE study of  RSV infections treatment
January 12, 2017 Off

Ablynx starts Phase IIb RESPIRE study of RSV infections treatment

By Dino Mustafić

Ablynx has dosed the first patient in the Phase IIb “RESPIRE” dose-ranging efficacy study of ALX-0171, its novel inhaled drug…

January 12, 2017 Off

FDA warns about cancer drug

By Dino Mustafić

The Food and Drug Administration is warning consumers not to purchase or use PNC-27, a product promoted and sold through http://PNC27.com,…

Celyad: First pancreatic cancer patient in its CAR-T NKR-2THINK trial in Belgium
January 12, 2017 Off

Celyad: First pancreatic cancer patient in its CAR-T NKR-2THINK trial in Belgium

By Dino Mustafić

Celyad has activated a second clinical site in Belgium for the , with the registration of a pancreatic cancer patient…

January 11, 2017 Off

Man from Bosnia finds cure for multiple sclerosis in canabis

By Dino Mustafić

A man from Bosnia has reportedly cured multiple sclerosis with cannabis oil. He was talking to CNN affiliate in Bosnia where he spoke about the hardest moments in his life, hearing about suffering from incurable disease.

Eli Lilly, Merck expand collaboration against cancer
January 11, 2017 Off

Eli Lilly, Merck expand collaboration against cancer

By Dino Mustafić

Eli Lilly and Merck have expand an existing immuno-oncology collaboration through a subsidiary to add a new study of Lilly’s…

Posts pagination

Previous 1 … 3,528 3,529 3,530 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine